Nuchev Pty Ltd · ASX:NUC
Nuchev Pty — Shareholder Meeting (November 2023)
19 slides from Nuchev Pty's shareholder meeting presentation, Nov 29, 2023
Slide 1: Annual General Meeting Chair's Address and Operational Update
ASX ANNOUNCEMENT | 29 November 2023 Annual General Mee�ng Chair’s Address and Opera�onal Update Nuchev Limited (ASX: NUC) (Nuchev or the Company) is pleased to release the following Chair’s Address and Operational Update Presentation which will be delivered to Shareholders at the Company’s Annual Ge
Slide 2: Chair's Address
ASX ANNOUNCEMENT | 29 November 2023 Chair’s Address Nuchev Ltd | AGM | 11.00am AEDT | 29 November 2023 A YEAR OF TRANSFORMATION We made significant changes to our China operations that will underwrite growth over the next three years, strengthened our capital base and cash position, maintained, and
Slide 3: Chair's Address (continued)
ASX ANNOUNCEMENT | 29 November 2023 Domestically our business is strong, and our market share and volume continue to increase, demonstrating that consumers appreciate the benefits of the product as shown by Oli6® being voted the #1 Toddler Drink on Product Review for the third consecutive year. Our
Slide 4: 2023 Annual General Meeting
2023 Annual General Meeting Wednesday 29 November 2023 at 11.00am AEDT For personal use only years of functional foods for a better life
Slide 5: Acknowledgement of Country
Acknowledgement of Country For personal use only I would like to acknowledge the traditional custodians of the land on which our office is located, the Wurundjeri People of the Kulin nation, and pay my respects to the Elders, past, present and emerging. Directors and Shareholders are joining from ot
Slide 6: Board of Directors
Board of Directors For personal use only Ben Dingle Jeff Martin Michelle Terry Craig Silbery Non-Executive Director and Chair Non-Executive Director Non-Executive Director Non-Executive Director 3
Slide 7: Executive Leadership Team and Company Secretary
Executive Leadership Team and Company Secretary For personal use only Greg Kerr Tamara Barr Mick Myers Chief Executive Officer Company Secretary Chief Financial Officer 4
Slide 8: Our Purpose
Our Purpose Functional foods for a better life For personal use only We are committed to improving families’ lives Demonstrated by Leadership in premium digestion and immunity • Backed by science • Fueled by consumer led innovation • World class ingredients Supported through Premium nutrition • Cons
Slide 9: Our growth strategy
Our growth strategy For personal use only 10
Slide 10: FY24 Q1 Results Update
FY24 Q1 Results Update The new strategic distribution agreement with H&S Group has delivered growth with sales in China Cross Border For personal use only e-Commerce (CBEC), up 190% QoQ1 and up 300% pcp2 Revenue from branded sales of Oli6® of $3.6m for the quarter, up 89% QoQ and up 126% pcp I
Slide 11: FY24 Q1 Sales Revenue and Volumes
FY24 Q1 Sales Revenue and Volumes Net Branded Revenue ($ millions) For personal use only Branded Volume (MT or metric tonnes) 120.0 4.0 109.3 3.6 3.5 100.0 3.0 80.0 2.5 2.2 63.3 2.0 1.9 1.8 60.0 53.9 1.6 51.2 51.6 1.5 40.0 1.0 0.5 20.0 - Q1 FY23 Q2 FY23 Q3 FY23 Q4 FY23 Q1 FY24 - Q1 FY23 Q2 FY23 Q3 F
Slide 12: FY23 Key performance metrics
FY23 Key performance metrics Commentary For personal use only FY23 FY22 % change Oli6® sales volume1 and revenue1 (excluding sales of raw material ingredients) in FY23 increased by 6.5% and 3.5% pcp3, respectively Volume1 (mT) 230 216 +6.5% Adjusted EBITDA2 improved $2.9m or 28% pcp Oli6® sales
Slide 13: FY23 financial and operational performance
FY23 financial and operational performance Volumes1 (Metric Tonnes) Higher volumes 1 For personal use only 250 Total sales volumes increased in H2 FY23 200 117 FY23 sales volumes up 6% pcp2 150 106 100 Increased branded sales revenue 50 113 109 FY23 branded revenue of $7.5m were up $255k or 3.
Slide 14: FY23 Branded Adjusted EBITDA
FY23 Branded Adjusted EBITDA $ millions FY23 FY22 Sales revenue1 up For personal use only Oli6 Sales Revenue (excluding raw material sales) 7.5 7.2 Oli6® sales revenue increased $256k or 3.5% pcp2 Cost of sales (excluding raw material sales) (5.0) (4.5) ANZ sales increased $1.15m or 26% pcp, wit
Slide 15: Improved operating cashflow
Improved operating cashflow Net cash flows used in operations Disciplined cashflow and working capital management For personal use only 9.0 8.3 has delivered substantial cash savings 8.0 Disciplined cost control measures combined with improved working 7.0 2.4 capital management practices, have enabl
Slide 16: Balance Sheet
Balance Sheet $ millions 30 June 2023 30 June 2022 Cash increased $2.4m pcp1 For personal use only Cash and short term deposits 7.5 5.1 Trade and other receivables 0.7 1.6 Closing cash position of $7.5m at 30 June 2023, an improvement of Prepayments 1.1 0.5 $2.4m or 47% pcp Inventories 5.3 9.4 R
Slide 17: Focusing on our Future
Focusing on our Future For personal use only
Slide 18: Repositioning strategy for profitable scalable growth
Repositioning strategy for profitable scalable growth MAINTAIN OUR CURRENT PURPOSE For personal use only PURPOSE FOOD FOR A BETTER LIFE CURRENT FUTURE PRODUCT Single minded focus on goat Leading premium digestion, Immunity and wellness nutritional's in multi-categories POSITIONING Specialist infant
Slide 19: Disclaimer
Disclaimer This presentation has been prepared for publication in Australia and may not be released to US wire services or distributed in the United States. In particular, this presentation does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or